FOSTER CITY, Calif. - Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical company, has announced a 2.7% increase in its quarterly cash dividend. This increment raises the dividend to $0.77 per share of common stock, effective for the first quarter of 2024. The upcoming dividend is scheduled to be paid on March 28, 2024, to shareholders who are on record as of March 15, 2024.
Gilead Sciences is known for its significant contributions to medicine over the past three decades, focusing on the development of innovative treatments for critical diseases such as HIV, viral hepatitis, COVID-19, and cancer. With its global operations extending to over 35 countries and its headquarters based in Foster City, California, Gilead continues to emphasize its dedication to advancing healthcare and treatment options around the world.
The information in this article is based on a press release.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.